Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study

Noth, 2013, Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study, Lancet Respir Med, 1, 309, 10.1016/S2213-2600(13)70045-6 Fingerlin, 2013, Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis, Nat Genet, 45, 1409, 10.1038/ng1113-1409a O'Dwyer, 2013, The toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 188, 1442, 10.1164/rccm.201304-0760OC Peljto, 2013, Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis, JAMA, 309, 2232, 10.1001/jama.2013.5827 Herazo-Maya, 2013, Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis, Sci Transl Med, 5, 205ra136, 10.1126/scitranslmed.3005964 Gilani, 2010, CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis, PLoS One, 5, e8959, 10.1371/journal.pone.0008959 Rosas, 2008, MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis, PLoS Med, 5, e93, 10.1371/journal.pmed.0050093 Molyneaux, 2013, The role of infection in the pathogenesis of idiopathic pulmonary fibrosis, Eur Respir Rev, 22, 376, 10.1183/09059180.00000713 Shulgina, 2013, Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial, Thorax, 68, 155, 10.1136/thoraxjnl-2012-202403 Han, 2012, Significance of the microbiome in obstructive lung disease, Thorax, 67, 456, 10.1136/thoraxjnl-2011-201183 Naik, 2012, Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis, Am J Physiol Lung Cell Mol Physiol, 303, L1046, 10.1152/ajplung.00139.2012 Mason, 2012, Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy, Infect Immun, 80, 3371, 10.1128/IAI.00449-12 Daigle, 2011, High-throughput sequencing of PCR products tagged with universal primers using 454 life sciences systems, Curr Protoc Mol Biol, 10.1002/0471142727.mb0705s96 Raghu, 2011, An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management, Am J Respir Crit Care Med, 183, 788, 10.1164/rccm.2009-040GL Flaherty, 2007, Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?, Am J Respir Crit Care Med, 175, 1054, 10.1164/rccm.200606-833OC Flaherty, 2004, Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?, Am J Respir Crit Care Med, 170, 904, 10.1164/rccm.200402-147OC Collard, 2007, Acute exacerbations of idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 176, 636, 10.1164/rccm.200703-463PP Schloss, 2009, Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities, Appl Environ Microbiol, 75, 7537, 10.1128/AEM.01541-09 Hastie, 2009 Tian, 2011, Adaptive index models for marker-based risk stratification, Biostatistics, 12, 68, 10.1093/biostatistics/kxq047 Han, 2008, Sex differences in physiological progression of idiopathic pulmonary fibrosis, Eur Respir J, 31, 1183, 10.1183/09031936.00165207 2012, Evaluation of 16S rDNA-based community profiling for human microbiome research, PLoS One, 7, e39315, 10.1371/journal.pone.0039315 Maher, 2007, Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?, Eur Respir J, 30, 835, 10.1183/09031936.00069307 2012, Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis, N Engl J Med, 366, 1968, 10.1056/NEJMoa1113354 McMillan, 2008, Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus, Am J Respir Crit Care Med, 177, 771, 10.1164/rccm.200708-1184OC Wootton, 2011, Viral infection in acute exacerbation of idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 183, 1698, 10.1164/rccm.201010-1752OC Konishi, 2009, Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 180, 167, 10.1164/rccm.200810-1596OC Erb-Downward, 2011, Analysis of the lung microbiome in the “healthy” smoker and in COPD, PLoS One, 6, e16384, 10.1371/journal.pone.0016384 Hilty, 2010, Disordered microbial communities in asthmatic airways, PLoS One, 5, e8578, 10.1371/journal.pone.0008578 Huang, 2010, A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations, OMICS, 14, 9, 10.1089/omi.2009.0100 Garzoni, 2013, Microbial communities in the respiratory tract of patients with interstitial lung disease, Thorax, 68, 1150, 10.1136/thoraxjnl-2012-202917 Richter, 2009, Pulmonary infection in Wegener granulomatosis and idiopathic pulmonary fibrosis, Thorax, 64, 692, 10.1136/thx.2008.110445 Varney, 2008, A double blind randomised placebo controlled pilot study of oral co-trimoxazole in advanced fibrotic lung disease, Pulm Pharmacol Ther, 21, 178, 10.1016/j.pupt.2007.02.001 Trujillo, 2010, TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis, Sci Transl Med, 2, 57ra82, 10.1126/scitranslmed.3001510 Parker, 2012, Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9, J Immunol, 189, 4040, 10.4049/jimmunol.1201055 Raghu, 2006, High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis, Eur Respir J, 27, 136, 10.1183/09031936.06.00037005 Morris, 2013, Comparison of the respiratory microbiome in healthy nonsmokers and smokers, Am J Respir Crit Care Med, 187, 1067, 10.1164/rccm.201210-1913OC Raghu, 2012, Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials, Am J Respir Crit Care Med, 185, 1044, 10.1164/rccm.201201-0006PP